CD83 and neoplasm: As shown in Figure 3H–J, CD11c+/CD83+/MHC‐II+ DCs in the spleen, tumour‐draining lymph nodes, and tumour‐infiltrating lymphocytes were 1.5–2 times more abundant in the magnolol plus RT group compared to the control group.